Cinqair

Generic name: Reslizumab
Drug class: Interleukin inhibitors

Usage of Cinqair

Cinqair is a monoclonal antibody that affects the actions of the body's immune system. Reslizumab works by reducing levels of a certain type of white blood cell that may contribute to the symptoms of asthma.

Cinqair is a prescription medicin eused together with other medicines to help control severe asthma.

Cinqair is used in people aged 18 years of age and older whose asthma is not controlled by their current asthma medicines.

Cinqair side effects

Get emergency medical help if you have signs of an allergic reaction to Cinqair: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during or shortly after the injection. Tell your caregiver if you feel dizzy, nauseated, light-headed, itchy, short of breath, or if you have swelling in your face.

Common Cinqair side effects may include:

sore throat; or

muscle pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Cinqair

You should not be treated with Cinqair if you are allergic to reslizumab.

To make sure Cinqair is safe for you, tell your doctor if:

you also use steroid asthma medication; or

you have ever had a parasite infection (such as roundworms or tapeworms).

Using Cinqair may increase your risk of developing cancer. Ask your doctor about this risk.

Tell your doctor if you are pregnant. It is not known whether reslizumab will harm an unborn baby. However, having uncontrolled asthma during pregnancy may cause premature birth, a low birth weight baby, or complications such as eclampsia (dangerously high blood pressure that can lead to medical problems in both mother and baby). The benefit of treating asthma may outweigh any risks to the baby.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Relate drugs

How to use Cinqair

Usual Adult Dose for Asthma:

3 mg/kg IV over 20 to 50 minutes every 4 weeks Comments: -Do not administer as an IV push or bolus. -The infusion should be discontinued immediately if the patient experiences a severe systemic reaction, including anaphylaxis. Use: For the add-on maintenance treatment of patients with severe asthma with an eosinophilic phenotype

Warnings

Some people have had allergic reactions to Cinqair during or shortly after the injection. Tell your caregiver if you feel nauseated, light-headed, itchy, or have swelling in your face or trouble breathing.

You will be watched closely after receiving Cinqair, to make sure you do not have an allergic reaction.

What other drugs will affect Cinqair

Other drugs may interact with reslizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Popular FAQ

Cinqair (reslizumab) does not treat all types of asthma. It has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance therapy to treat patients with severe asthma, aged 18 years and older, who have an eosinophilic phenotype. Cinqair is not used to treat other types of asthma, other eosinophilic conditions, or used as a rescue medication for asthma attacks. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.